Search

AI breakthrough in detecting leading cause of childhood blindness

An artificial intelligence (AI) tool could be an effective way of identifying retinopathy of prematurity (ROP), the leading cause of childhood blindness in middle-income countries, finds a new study led by UCL and Moorfields Eye Hospital researchers.

WATCH: Novel imaging technology reveals role of immune cells in early diabetic cataract development

In this video interview, Proffessor Ali Hafezi-Moghadam and Professor Dr. Christoph Rußmann discuss their findings on the role of immune cells in early diabetic cataract development.

Charles Bonnet Syndrome emerges from the shadows

There has been a ground-breaking response to the online Charles Bonnet Syndrome Patient Information event on 16 November.

Dr Sohaib Rufai awarded European Award in Medicine for Ophthalmology

Dr Sohaib Rufai has been awarded the 2022 European Award in Medicine for Ophthalmology. He led the world’s first study using handheld OCT to predict future vision in infantile nystagmus.

Preview: RCN Ophthalmic Nursing Conference 2024

by Tendai Gwenhure, Clinical Educator, Moorfields Eye Hospital; Programme Lead, UCL Institute of Ophthalmology; Chair, RCN Ophthalmic Nursing Forum. The Royal College of Nursing (RCN) Ophthalmic Nursing Forum (ONF) is a long-standing professional network within the RCN that is dedicated...

OKKO Health announce collaboration with the University of Plymouth to measure vision in extreme environments including space

OKKO Health, a leader in innovative eye health technology, is excited to announce its collaboration with the University of Plymouth. This groundbreaking project will test eye health and track early disease detection in extreme environments, beginning with the depths of a cave and soon to monitor astronauts’ vision in the vastness of space.

LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation

Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...

Oriel celebrates breaking ground milestone

A special breaking ground celebration was held on 11 July to mark the start of construction to build Oriel, a new eyecare, research and education centre in Camden.

PREVIEW: Join us at the TROPHY Ophthalmic Conference 2025!

The highly anticipated TROPHY Ophthalmic Conference returns this year with an impressive lineup of experts, cutting-edge technological advances, and engaging discussions that promise to strengthen the field of ophthalmology. The TROPHY Ophthalmic Conference is Trent Ophthalmic Society's flagship event, provides...

BCLA ASIA 2024 triumphantly takes place in Chengdu, China

The British Contact Lens Association (BCLA) marked an historic milestone with the successful staging of BCLA ASIA in mainland China.

New President and President-elect of the UK and Éire Glaucoma Society (UKEGS) announced

Glaucoma UK has announced the appointments of the new President and President-elect for the UK and Éire Glaucoma Society (UKEGS). Taking over from Ms Nishani Amerasinghe, the 2025 President is Dr Andrew Tatham who is a consultant at Princess Alexandra...

New study uncovers key mechanism behind a common genetic cause of age-related visual loss

A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...